pI: 8.0073 |
Length (AA): 473 |
MW (Da): 51606 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
267 | 487 | 1wkc (A) | 3 | 175 | 27.00 | 0 | 0.99 | 0.24 | 0.76 |
151 | 254 | 1udx (A) | 65 | 152 | 38.00 | 0.048 | 0.24 | 0.345173 | 0.9 |
233 | 459 | 2jcb (A) | 0 | 183 | 23.00 | 0 | 1 | 0.489615 | 0.62 |
249 | 459 | 1wkc (A) | 5 | 167 | 33.00 | 0 | 1 | 0.414789 | 0.63 |
339 | 383 | 3hy3 (A) | 109 | 157 | 49.00 | 0.0014 | 0.16 | 0.386437 | 1.26 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Hehl AB Fritz HM Sibley/Greg |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_127997)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G13050 | 5-formyltetrahydrofolate cycloligase |
Candida albicans | CaO19.4523 | similar to S. cerevisiae YER183C |
Candida albicans | CaO19.11998 | similar to S. cerevisiae YER183C |
Caenorhabditis elegans | CELE_Y106G6E.4 | Protein Y106G6E.4 |
Chlamydia trachomatis | CT_649 | formyltetrahydrofolate synthetase |
Drosophila melanogaster | Dmel_CG34424 | CG34424 gene product from transcript CG34424-RA |
Escherichia coli | b2912 | 5-formyltetrahydrofolate cyclo-ligase family protein |
Echinococcus granulosus | EgrG_000773800 | 5 formyltetrahydrofolate cyclo ligase |
Echinococcus multilocularis | EmuJ_000773800 | 5 formyltetrahydrofolate cyclo ligase |
Homo sapiens | 10588 | 5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) |
Homo sapiens | 100528021 | ST20-MTHFS readthrough |
Mycobacterium leprae | ML0181c | Conserved hypothetical protein |
Mus musculus | ENSMUSG00000079427 | predicted gene 2382 |
Mus musculus | ENSMUSG00000066442 | 5, 10-methenyltetrahydrofolate synthetase |
Mycobacterium tuberculosis | Rv0992c | Conserved hypothetical protein |
Mycobacterium ulcerans | MUL_4694 | hypothetical protein |
Neospora caninum | NCLIV_002980 | 5-formyltetrahydrofolate cyclo-ligase domain- containing protein, putative |
Oryza sativa | 4343714 | Os07g0578600 |
Saccharomyces cerevisiae | YER183C | 5-formyltetrahydrofolate cyclo-ligase |
Schistosoma japonicum | Sjp_0202250 | ko:K01934 5-formyltetrahydrofolate cyclo-ligase [EC6.3.3.2], putative |
Schistosoma mansoni | Smp_087230 | 5-formyltetrahydrofolate cyclo-ligase |
Schmidtea mediterranea | mk4.003655.01 | Probable 5-formyltetrahydrofolate cyclo-ligase |
Toxoplasma gondii | TGME49_208090 | 5-formyltetrahydrofolate cyclo-ligase |
Treponema pallidum | TP0694 | 5,10-methenyltetrahydrofolate synthetase |
Wolbachia endosymbiont of Brugia malayi | Wbm0256 | 5-formyltetrahydrofolate cyclo-ligase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1008 | Mycobacterium tuberculosis | non-essential | nmpdr |
b2912 | Escherichia coli | non-essential | goodall |
TGME49_208090 this record | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.